Capital Group Investment Management Pte. Ltd. Teva Pharmaceutical Industries LTD Transaction History

Capital Group Investment Management Pte. Ltd.

$444 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $558,504 - $734,587	-77,570 Reduced 87.93%	10,651 $80,000
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $73,108 - $99,430	-8,745 Reduced 9.02%	88,221 $780,000
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $770,879 - $919,237	96,966 New	96,966 $0

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$747 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$631 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$600 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$501 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$460 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.

Account